StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3053% below fair value
$43.64+0.61 (+1.42%)

Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –

Boston Scientific GAAP EBITDA by Quarter

GAAP EBITDA ($M) ($M)

Boston Scientific GAAP EBITDA: $1,191M in Q3 2026, down 12.6% from a year earlier.

Latest, Q3 2026
1,191
Period ended Sep 30, 2026
Change on a year earlier
-12.6%
1,362 in Q3 2025
History
18 quarters
Since Q2 2022
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“EBITDA 1,141 1,588 1,500 1,191 $ 5,419”

Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗

Reported in Quarterly FOH Appendix C.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP EBITDA ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20261,191-12.6%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q2 2026Jun 30, 20261,500+10.0%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q1 2026Mar 31, 20261,588+31.6%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q4 2025Dec 31, 20251,141+15.3%BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Q3 2025Sep 30, 20251,362+34.5%BSX FY2026Q2 Financial & Operational Highlights Presentation ↗
Q2 2025Jun 30, 20251,364+75.3%BSX FY2026Q1 Financial & Operational Highlights Presentation ↗
Q1 2025Mar 31, 20251,207+24.8%BSX FY2025Q4 Financial & Operational Highlights Presentation ↗
Q4 2024Dec 31, 2024990+13.4%BSX FY2025Q3 Financial & Operational Highlights Presentation ↗
Q3 2024Sep 30, 20241,013+4.3%BSX FY2025Q2 Financial & Operational Highlights Presentation ↗
Q2 2024Jun 30, 2024778-1.8%BSX FY2025Q1 Financial & Operational Highlights Presentation ↗
Q1 2024Mar 31, 2024967+22.9%BSX FY2024Q4 Financial & Operational Highlights Presentation ↗
Q4 2023Dec 31, 2023873+16.4%BSX FY2024Q3 Financial & Operational Highlights Presentation ↗
Q3 2023Sep 30, 2023971+64.6%BSX FY2024Q2 Financial & Operational Highlights Presentation ↗
Q2 2023Jun 30, 2023792+14.5%BSX FY2024Q1 Financial & Operational Highlights Presentation ↗
Q1 2023Mar 31, 2023787–BSX FY2023Q4 Financial & Operational Highlights Presentation ↗
Q4 2022Dec 31, 2022750–BSX FY2023Q3 Financial & Operational Highlights Presentation ↗

Cite this data

StockData. (2026). Boston Scientific GAAP EBITDA ($M), quarterly Q2 2022–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-gaap-ebitda

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?